Abstract
Newer biological agents like belatacept may replace CNIs/corticosteroids in renal transplant recipients, with a benefit of better short-term and long-term renal function, better compliance, and ultimately a possible improvement in long-term renal allograft survival.
| Original language | English |
|---|---|
| Pages (from-to) | 573-577 |
| Number of pages | 5 |
| Journal | Current Opinion in Organ Transplantation |
| Volume | 19 |
| Issue number | 6 |
| DOIs | |
| State | Published - 2014 |
| Externally published | Yes |
Keywords
- Belatacept
- Calcineurin inhibitor toxicity
- Costimulation blockade
- Immunosuppression
- Kidney transplantation